Screener
Cullinan Therapeutics, Inc. CGEM Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Liquidity | ||||||
| Current ratio | 8.4×-1.4× | 10.3×-1.3× | 10.2×-3.3× | 10.4×-14.0× | 9.8×-19.0× | |
| Valuation | ||||||
| Market capitalization | $1.16B+148% | $860.08M+94.2% | $611.44M-13.8% | $350.31M-62.0% | $462.67M-38.3% |
FAQ
- Where do Cullinan Therapeutics, Inc.'s ratios come from?
- Every ratio is computed from Cullinan Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.